Period:
Draw Mode:
| Volume | 75,099 |
|
|||||
| News | - | ||||||
| Day High | 2.87 | Low High |
|||||
| Day Low | 2.60 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Nautilus Biotechnology Inc | NAUT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.21 | 7.98% | 2.84 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.61 | 2.60 | 2.87 | 2.84 | 2.63 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 587 | 75,099 | $ 2.74 | $ 206,098 | - | 1.50 - 3.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:52:35 | 1 | $ 2.85 | USD |
Nautilus Biotechnology Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 354.62M | 124.87M | 56.79M | $ - | $ - | -0.46 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 1.89M | 25.00% |
Nautilus Biotechnology News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NAUT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.42 | 2.87 | 2.29 | 2.48 | 71,037 | 0.42 | 17.36% |
| 1 Month | 2.54 | 2.87 | 2.16 | 2.41 | 59,808 | 0.30 | 11.81% |
| 3 Months | 2.20 | 2.87 | 2.00 | 2.43 | 97,729 | 0.64 | 29.09% |
| 6 Months | 1.76 | 2.87 | 1.50 | 2.07 | 118,757 | 1.08 | 61.36% |
| 1 Year | 3.47 | 3.98 | 1.50 | 2.50 | 192,395 | -0.63 | -18.16% |
| 3 Years | 11.49 | 12.38 | 1.50 | 5.21 | 328,365 | -8.65 | -75.28% |
| 5 Years | 11.49 | 12.38 | 1.50 | 5.21 | 328,365 | -8.65 | -75.28% |
Nautilus Biotechnology Description
| Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System. |